| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |